The COVID Moonshot is a highly accelerated discovery project aiming to identify an orally available treatment for COVID-19. In order to perform all preclinical activities required to enable Phase I studies, DNDi is now sourcing a Contract Research Organization (CRO) offering an integrated platform capable of delivering the nonclinical safety and toxicology aspects of the project.